INS and diabetic kidney disease: Based on the significant differences in metabolic biomarkers between ND-DKD and newly diagnosed type 2 diabetes mellitus patients, our study selected insulin, C-peptide, and lipoproteins to explore potential biomarkers for predicting DKD (30).